drugset / Trial / NCT00719602

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

NCT00719602

RandomizedParallel-groupDouble-blindTreatment

Summary

More than 1.5 million deaths of African children under 5 years of age have been due to Plasmodium falciparum malaria. When HIV and malaria are present as coinfections, they enhance each other's progression. The primary purpose of this study is to compare the malarial infection levels in HIV-infected infants and children receiving protease inhibitor (PI)- or non-nucleotide reverse transcriptase inhibitor (NNRTI)-based highly active antiretroviral therapy (HAART).

Timeline

Start
2009-08
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lopinavir/Ritonavir Unknown Oral
Comparator Nevirapine Small molecule Oral
Comparator Lamivudine Other / unclassified Oral
Comparator Zidovudine Small molecule Oral